Lymphokine activated killer cells in murine coxsackievirus B3 myocarditis

Basic Research in Cardiology

Volumn 92, Issue 6, 1997, Pages 402-409

  Kishimoto, C ^a   Kuroki, Y ^a   Kurokawa, M ^a   Ohiai, H ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cox sackievirus B3; Cytotoxic reaction; Interleukine 2; Lymphokine activated killer cell; Myocarditis

Indexed keywords

LYMPHOKINE; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOTOXICITY; LYMPHOCYTE CULTURE; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MOUSE; MUSCLE CELL; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL; VIRUS MYOCARDITIS;

EID: 0031471537     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00796214     Document Type: Article

References (26)

1. Abelmann WH (1971) Virus and the heart. Circulation 44: 950-956
2. Chang AE, Hyatt CL, Rosenberg SA (1984) Systemic administration of recombinant human interleukin-2 in mice. J Biol Response Mod 3: 561-568
3. Dec GW Jr, Palacios IF, Fallon JT, Aretz T, Millis J, Lee DCS, Johnson RA (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies. N Engl J Med 312: 885-990
4. + helper cell and IL-2 independent in Balb/c mice. Am J Pathol 127: 335-341
5. Estrin M, Smith C, Huber SA (1986) Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporine-A treatment. Am J Pathol 125: 244-251
6. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1832-1841
7. Huber SA, Job LP, Woodruff JF (1980) Lysis of infectedmyofibers by coxsackievirus B3-immune T lymphocytes. Am J Pathol 98: 681-694
8. Huber SA, Lodge PA (1984) Coxsackievirus B3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 116: 21-29
9. Huber SA, Polgar J, Schultheiss P, Schwimmbeck P (1994) Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J Virol 68: 195-206
10. Kawai C (1971) Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J: 765-768
11. Kishimoto C, Abelmann WH (1989) Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice. Circulation 79: 1300-1308
12. Kishimoto C, Abelmann WH (1989) Absence of effects of cyclosporine on myocardial lymphocyte subsets in coxsackievirus B3 myocarditis in the aviremic stage. Circ Res 65: 934-945
13. Kishimoto C, Misaki T, Crumpacker CS, Abelmann WH (1988) Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation 77: 645-653
14. Lanier LL, Benike CJ, Phillips JH, Engleman EG (1985) Recombinant interleukin-2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol 134: 794-801
15. Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC (1983) Characterization of the human receptor for T-cell growth factor. Immunology 80: 6957-6961
16. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41: 4420-4425
17. Mule JJ, Shu S, Schwarz SL, Rosenberg SA (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225: 1487-1489
18. Mule JJ, Yang JC, Afreniere RL, Shu S, Rosenberg SA (1987) Identification of cellular mechanisms operated in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J Immunol 139: 285-294
19. Nakamura TY, Yamamoto I, Kanno Y, Shiba Y, GoshimMa K (1994) Metabolic coupling of glutathione between mouse and quail cardiac myocytes and its protective role against oxidative stress. Circ Res 74: 806-816
20. Paque RE, Gauntt CJ, Nealon TJ, Trousdale MD (1978) Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol 120: 1672-1678
21. Ryes M, Lerner AM (1985) Coxsackievirus myocarditis. With special reference to acute and chronic effects. Prog Cardiovasc Dis 27: 373-394
22. Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA (1984) Lymphokine-activated killer cells. Lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res 44: 1946-1953
23. Saijo N, Ozaki A, Nakano H, Sakurai M, Takahashi H, Sasaki Y, Hoshi A (1986) In vivo augmentation of the cytotoxity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2). J Cancer Res Clin Oncol 111: 182-186
24. Weibel ER, Kistler GS, Scherte WF (1966) Practical stereological methods for morphometric cytology. J Cell Biol 30: 23-38
25. Woodruff JF, Woodruff JJ (1974) Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J Immunol 113: 1726-1734
26. Woodruff JF (1980) Viral myocarditis. A review. Am J Pathol 101: 427-479